NEVVI Medicare utilization intelligence
or

← back

Provider profile

CHANG, JOHNNY MD

Hematology-Oncology · NPI 1366465304 · ENCINO, CA

1
Groups
50
Codes · 2024
104,041
Disclosed services

CHANG, JOHNNY is a Hematology-Oncology in ENCINO, CA, a member of 1 medical group, who billed 50 distinct codes to Medicare Part B in 2024.

Groups: CEDARS-SINAI MEDICAL CARE FOUNDATION (LOS ANGELES, CA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

104,041
disclosed services
50
codes billed to Medicare Part B
Prior year · CY2023 109,293 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J0897 Injection, denosumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1626 Injection, granisetron hydrochloride, 100 mcg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
36415 Insertion of needle into vein for collection of blood sample
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J0640 Injection, leucovorin calcium, per 50 mg
96375 Injection of additional new drug or substance into vein
J9190 Injection, fluorouracil, 500 mg
96372 Injection of drug or substance under skin or into muscle
J2469 Injection, palonosetron hcl, 25 mcg
J9045 Injection, carboplatin, 50 mg
Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
96413 Administration of chemotherapy into vein, 1 hour or less
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96417 Administration of additional new drug or substance into vein, 1 hour or less
82378 Carcinoembryonic antigen (cea) protein level
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96415 Administration of chemotherapy into vein, each additional hour
82607 Cyanocobalamin (vitamin b-12) level
82746 Folic acid level, serum
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
J7030 Infusion, normal saline solution , 1000 cc
82248 Bilirubin level, direct
85045 Red blood count, automated test
84153 Psa (prostate specific antigen) measurement, total
96360 Infusion into a vein for hydration, 31-60 minutes
96361 Infusion into a vein for hydration, each additional hour
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
83735 Magnesium level
96374 Injection of drug or substance into vein
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
83615 Lactate dehydrogenase (enzyme) level

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.